Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

QDVO is concentrated in large-cap growth, especially tech, with high income potential but notable liquidity and volatility ...

Nike’s fading moat, weak innovation, and revenue headwinds raise concerns despite signs of a turnaround. Find out why NKE ...

PHYS offers secure, liquid exposure to gold as momentum cools amid strong fundamentals, central bank buying, and bullish ...

Prescription drug claim denials by U.S. insurers rose 25% from 2016-2023, according to a new analysis of more than 4B medical ...

Fresh Del Monte has an improved balance sheet risk profile as debt has come down. Click here to see why FDP stock is a Buy.

FDVV's portfolio blends high-dividend growth and value stocks, limiting downside risk and capitalizing on tech and AI sector ...

Lowe's growth is backed by expanding the Pro segment and aggressive buybacks. Click here to see why LOW stock is a Buy.

Looking specifically at fast-casuals—the category in which El Pollo Loco fits—the situation is not as good as it was a year ...

Despite the gradual pace of AI monetization in advertising, Google Cloud delivered strong growth. Click here to read why GOOG ...

Graham has successfully transitioned to defense and space, doubling revenues and expanding margins. Read why I remain ...

Oil prices showed little reaction to the EU’s latest sanction package against Russia. However, it could lead to further ...